zindoxifene has been researched along with Breast Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| von Angerer, E | 1 |
| Alba, E; Colla, F; Farina, C; Mazzoleni, A; Ragonesi, G | 1 |
| Coombes, RC; Cunningham, DC; Davenport, J; Dowsett, M; Ford, HT; Gazet, JC; Stein, RC; von Angerer, E | 1 |
| Jordan, VC; Tormey, DC | 1 |
| Jordan, VC; Koch, R; Robinson, SP | 1 |
| Berger, M; Prekajac, J; von Angerer, E | 1 |
2 review(s) available for zindoxifene and Breast Neoplasms
| Article | Year |
|---|---|
[Antiestrogen therapy in the treatment of breast neoplasms].
Topics: Adult; Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Enzyme Inhibitors; Estrogen Antagonists; Female; Forecasting; Humans; Indoles; Letrozole; Middle Aged; Neoplasm Metastasis; Nitriles; Osteoporosis; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Toremifene; Triazoles | 2002 |
Antiestrogen therapy for breast cancer: current strategies and future prospects.
Topics: Breast Neoplasms; Estrogen Antagonists; Female; Humans; Indoles; Tamoxifen; Toremifene | 1988 |
4 other study(ies) available for zindoxifene and Breast Neoplasms
| Article | Year |
|---|---|
Development of new drugs for endocrine tumour chemotherapy.
Topics: Animals; Breast Neoplasms; Estrogen Antagonists; Female; Humans; In Vitro Techniques; Indoles; Mammary Neoplasms, Experimental; Menopause; Mice; Models, Biological; Neoplasms, Hormone-Dependent; Rats; Rats, Inbred Strains; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1984 |
Phase I/II study of the anti-oestrogen zindoxifene (D16726) in the treatment of advanced breast cancer. A Cancer Research Campaign Phase I/II Clinical Trials Committee study.
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Drug Evaluation; Estrogen Antagonists; Female; Humans; Indoles; Middle Aged | 1990 |
In vitro estrogenic actions in rat and human cells of hydroxylated derivatives of D16726 (zindoxifene), an agent with known antimammary cancer activity in vivo.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Division; Cell Line; Cells, Cultured; Estrogen Antagonists; Female; Humans; Hydroxylation; Indoles; Pituitary Gland; Prolactin; Rats; Rats, Inbred Strains; Receptors, Progesterone; Structure-Activity Relationship | 1988 |
The inhibitory effect of 5-acetoxy-2-(4-acetoxyphenyl)-1-ethyl-3-methylindole (D 16726) on estrogen-dependent mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Breast Neoplasms; Female; Humans; Indoles; Mammary Neoplasms, Experimental; Methylnitrosourea; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Rats; Rats, Inbred Strains; Receptors, Estrogen; Tamoxifen | 1985 |